RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,577 | +22.0% | 859 | 0.0% | 0.00% | – |
| Q2 2023 | $2,113 | -95.5% | 859 | -95.9% | 0.00% | – |
| Q1 2023 | $47,000 | +86937.0% | 20,981 | +35.3% | 0.00% | – |
| Q4 2022 | $54 | -100.0% | 15,503 | -9.3% | 0.00% | – |
| Q3 2022 | $633,000 | +108.2% | 17,092 | +7.0% | 0.00% | – |
| Q2 2022 | $304,000 | -28.8% | 15,976 | +0.8% | 0.00% | – |
| Q1 2022 | $427,000 | +155.7% | 15,850 | +113.5% | 0.00% | – |
| Q4 2021 | $167,000 | -41.0% | 7,424 | -31.2% | 0.00% | – |
| Q3 2021 | $283,000 | -15.3% | 10,786 | +3.3% | 0.00% | – |
| Q2 2021 | $334,000 | +3.1% | 10,442 | +13.6% | 0.00% | – |
| Q1 2021 | $324,000 | +25.1% | 9,191 | +13.9% | 0.00% | – |
| Q4 2020 | $259,000 | -1.1% | 8,070 | +15.6% | 0.00% | – |
| Q3 2020 | $262,000 | -5.4% | 6,982 | +12.9% | 0.00% | – |
| Q2 2020 | $277,000 | – | 6,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |